Sacubitril/valsartan (Entresto), 273
Salicylates, 849t, 852, 1187t, 1626, 1652, 2131t
ingestion of, assessment of, 67–70
Saquinavir (SQV), 128, 942t, 1579t
Scopolamine (Transderm-Scop), 468t
Second-generation triptans, 1239
Selective estrogen receptor modulators (SERMs), 2271
Selective phosphodiesterase 4 (PDE4) inhibitors, 417
Selective serotonin reuptake inhibitors (SSRIs), 1749
for critically ill patients, 1208
for depressive disorders, 1820
for panic disorder, 1748, 1749
Selegiline, 942t, 1251t, 1255, 1264
Septra (see Trimethoprim-sulfamethoxazole (TMP-SMX))
SERMs (see Selective estrogen receptor modulators (SERMs))
androgen deprivation therapy, 2097
Serotonin and norepinephrine reuptake inhibitors (SNRIs), 1748
androgen deprivation therapy, 2097
for critically ill patients, 1208
Sertraline (Zoloft), 1027t, 1738t, 1748, 1749
for depressive disorders, 1819t, 1820t, 1821t
Serum immunoglobulin E antibodies, 455–456
17-α hydroxyprogesterone (17-OHP), 995–996
Silvadene (see Silver sulfadiazine cream)
Silver sulfadiazine cream (Silvadene; Aquacel Ag; ConvaTec), 863
Simvastatin, 46t, 55, 57, 57t, 110t, 116, 117, 117t, 120t, 125, 258
Sinemet CR (see Carbidopa–Levodopa (CR))
Sirolimus, 120t, 128, 226, 722
for type 2 diabetes, 1135, 1139
for inflammatory bowel disease, 521t, 523–524
SMX (see Sulfamethoxazole (SMX))
SNRIs (see Serotonin and norepinephrine reuptake inhibitors (SNRIs))
in oral electrolyte solutions, 2161t
and respiratory alkalosis, 1672
in metabolic acidosis, 562–563
Sodium ferric gluconate complex, 614
Sodium–glucose transporter 2 (SGLT2) inhibitors
contraindications and precautions of, 1130
pharmacokinetics of, 1129–1130
Sodium polystyrene sulfonate (SPS), 586
Sodium zirconium cyclosilicate, for hyperkalemia, 586
Sorafenib (Nexavar), 470t, 1990
Spectrobid (see Bacampicillin)
Spiriva Respimat, for asthma, 399
Spironolactone (Antiandrogen), 543, 546, 580–581, 2261t
for polycystic ovary syndrome, 1012t
No comments:
Post a Comment
اكتب تعليق حول الموضوع